FIORE CANNABIS LTD.
(Formerly Citation Growth Corp.)
MANAGEMENT DISCUSSION & ANALYSIS
For the three and nine months ended September 30, 2021
Management’s Discussion and Analysis
The following management’s discussion and analysis (“MD&A”) of the financial condition and results of the operations of Fiore Cannabis Ltd., formerly Citation Growth Corp. and its subsidiaries (collectively, the “Company” or “Fiore”) constitutes management’s review of the factors that affected the Company’s financial and operating performance for the nine months ended September 30, 2021. The MD&A should be read in conjunction with the Company’s unaudited condensed interim consolidated financial statements for the three and nine months ended September 30, 2021 and 2020 and the notes related thereto (the “Interim Financial Statements”) and the annual audited consolidated financial statements for the for the fiscal period ended December 31, 2020 and fiscal year ended March 31, 2020. A copy of the Annual Financial Statements is posted on the SEDAR website, www.sedar.com.
The Interim Financial Statements were prepared in accordance with IAS 34 Interim Financial Reporting of International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). All information in this MD&A is current as of November 25, 2021, unless otherwise indicated. All dollar figures are expressed in thousands of Canadian dollars, except for share data, or unless otherwise noted.
Management is responsible for the information contained in this MD&A and its consistency with information presented to the Audit Committee and Board of Directors. The Interim Financial Statements and MD&A have been reviewed and approved by the Board of Directors on November 25, 2021.
This MD&A may contain forward-looking statements and should be read in conjunction with the cautionary statement on forward-looking statements